Skip to main content

Peer Review reports

From: The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

Original Submission
25 Apr 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
24 Apr 2015 Editorially accepted
8 May 2015 Article published 10.1186/s12885-015-1363-1

You can find further information about peer review here.

Back to article page